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miR-300 mediates Bmi1 function and regulates
differentiation in primitive cardiac progenitors
FM Cruz1, M Tomé1,2, JA Bernal1,3 and A Bernad*,1,2,3
B lymphoma Mo-MLV insertion region 1 (Bmi1) is a polycomb-family transcriptional factor critical for self-renewal in many adult
stem cells and human neoplasia. We sought to identify microRNAs regulated by Bmi1 that could play a role in multipotent cardiac
progenitor cell (CPC) decisions. We found that miR-300, a poorly characterized microRNA mapping in the Dlk1-Dio3 microRNA
cluster, was positively regulated by Bmi1 in CPCs. Forced expression of miR-300 in CPCs promoted an improved stemness
signature with a significant increase in Oct4 levels, a reduction in senescence progression and an enhanced proliferative status via
p19 activation and inhibition of p16 accumulation. Endothelial and cardiogenic differentiation were clearly compromised by
sustained miR-300 expression. Additionally, RNA and protein analysis revealed a significant reduction in key cardiac transcription
factors, including Nkx2.5 and Tbx5. Collectively, these results suggest that some functions attributed to Bmi1 are due to induction
of miR-300, which decreases the cardiogenic differentiation potential of multipotent CPCs in vitro and promotes self-renewal.
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Bmi1 (B lymphoma Mo-MLV insertion region 1), a member of
polycomb repressive complex 1 (PCR1), is a transcription
factor involved in multiple biological processes, including
embryonic development, organ formation, tumorogenesis,
and stem cell self-renewal and differentiation.1 Deficiency in
Bmi1 results in progressive postnatal growth retardation and
neurological defects, confirming that Bmi1 is required for the
self-renewal of stem cells in the peripheral and central nervous
systems, but not for their survival or differentiation.2 In the
absence of Bmi1, the cyclin-dependent kinase inhibitor
p16Ink4a is generally upregulated,2,3 reducing the rate of
cellular proliferation. BMI1 is downregulated by replicative
senescence in human fibroblasts and overexpression of BMI1
extends replicative life span, correlating with INK4A/ARF
deregulation.4 Bmi1 has been reported to play crucial roles
during the self-renewal and maintenance of hematopoietic,
intestinal, bronchioalveolar, pancreatic, prostate, lung, and
epithelial stem cells2–6 and more recently the tongue and
rodent incisors.7 Thus, Bmi1 is possibly the most universal
adult stem cell marker and a remarkable player inmany cancer
stem cells models.8,9 In all models tested, Bmi1 dependence
seems to distinguish stem cell self-renewal from committed
progenitor proliferation.2
Multiple functions have been ascribed to Bmi1, under-
scoring its broad importance in numerous processes. Bmi1
facilitates the repression of Hox genes to prevent inappropri-
ate differentiation and induces downregulation of Dickopf
(DKK) proteins, resulting in upregulation of the Wnt target
c-Myc, which in turn leads to transcriptional autoactivation of
Bmi1.7 Reinforcement of this positive feedback loop regulating
Bmi1 expression seems relevant in promoting cancer and
maintaining the stem cell phenotype.9,10 In addition, Bmi1 is
transcriptionally controlled by phosphorylatedNanog,11,12 and
is inhibited by a plethora of miRNAs that are significantly
downregulated in cancer models.12
Extensive studies on primed differentiation of murine
embryonic stem (ES) and adult stem cells have established
that efficient stem cell maintenance requires a highly
concerted regulation of gene expression,13,14 involving both
coding genes and noncoding RNAs (ncRNAs). Among the
regulatory elements involved in stem cell function, Oct4
protein, encoded by the Pou5f1 gene, is essential for the
stemness properties of ES cells and is a key regulator
of pluripotency in mammalian development. The Oct4
transcription factor is also indispensible for somatic cell
reprogramming. Besides transcription factors, microRNAs
(miRNAs) also play important roles in stem cell homeostasis.
miRNAs are an abundant class of small ncRNAs that regulate
the translation, stability, and localization of target messenger
RNAs. Functional studies in ES cells have demonstrated
critical roles for miRNAs, especially in regulating the balance
between self-renewal and differentiation.14,15 Less information
is available about the role(s) of specific miRNAs in the
regulation of adult stem cell systems, but some studies have
explored possible collaborations; for example, miR-142-3p
controls specification of definitive hemangioblasts during
ontogeny.16,17 Also, miR-21 strongly inhibits SOX2 expression
in human mesenchymal stem cells (MSCs), resulting in
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reduced clonogenic and proliferative potential and cell-cycle
arrest.18 Finally, Lin28a, a highly conserved RNA-binding
protein expressed during embryogenesis, plays important
roles in development, pluripotency, and metabolism (reviewed
in Shyh-Chang et al.19), and its expression in several adult
injury models improves repair processes in a manner
mediated by its inhibition of let-7 miRNA biogenesis.19
Regarding the involvement of miRNAs in Bmi1 regulation,
there are multiple descriptions of miRNAs targeting Bmi1 and
many of them impact the corresponding stem or cancer stem
cell function (Supplementary Table S1).
Adult resident cardiac stem/progenitor cells (CSCs/CPCs)
are implicated in homeostatic turnover of the adult
heart (reviewed in Malliaras et al.20). Among the different
populations of putative CSCs isolated to date (reviewed in
Martin-Puig et al.21 Urbanek et al.22 and Li et al.23), those
expressing surface markers such as c-kit, SCA1, ATP-binding
cassette Abcg2, or PDGFRα are the principal candidates.
Indeed, resident CPCs with genetic elimination of Sca1 do not
properly respond to pathological damage in vivo and show
impaired growth and survival in vitro.24 In another study,
Ellison et al.25 have proposed that cKIT+ CSCs are necessary
and sufficient for adult heart turnover, although a recent
lineage-tracing experiment questioned the relevance of cKIT+
CSCs to in vivo cardiomyocyte turnover.26 These authors
claimed that, in all probability, diversity in CSC populations
could be related to some heterogeneity within the CSC
compartment.25 Nevertheless, two clinical evaluations have
been initiated with promising results in early phases.27,28
Here, using murine CPCs, we attempted to identify miRNAs
that could be directly regulated by Bmi1. We hypothesized that
those miRNAs upregulated in parallel with Bmi1 could be
involved in the maintenance of the undifferentiated state.
Conversely, miRNAs downregulated with Bmi1 might be
involved in early commitment/differentiation decisions. We
show that miR-300 is positively regulated in parallel with Bmi1
expression in CPCs, while miR-188 andmiR-362 are inversely
regulated. Furthermore, we confirm that miR-300 is a target of
Bmi1 and show that forced expression of miR-300 favors the
undifferentiated state and impedes differentiation of CPCs.
Indeed, CPCs engineered to overexpress miR-300 exhibit
compromised spontaneous endothelial differentiation and
show a poor response to cardiomyogenic stimuli, an outcome
that is possibly mediated by severe inhibition of Nkx2.5
expression.
Results
Bmi1 regulates miR-300 expression in CPCs. Freshly
isolated Lin-SCA1+ CPCs (SCA1-CPCs) from heart are
defined as Cd45 negative and express a panel of
multipotency-related genes, including Tbx5, Klf4, c-Myc,
Bmi1, and Meg3, and a distinctive profile of endothelial,
fibroblast, and cardiac markers (Supplementary Figure S1).
To assess the potential involvement of Bmi1 in the control of
miRNA expression in SCA1-CPCs (hereafter named CPCs),
we transduced freshly isolated CPCs with lentiviral vectors
(Supplementary Figure S2a) engineered to overexpress or
silence Bmi1 (B+ and sh-Bmi1, respectively). We first
confirmed Bmi1 up- or downregulation in transduced cells
by RT-qPCR and western blotting (Figures 1a and b).
As expected, CPC-B+ cells grew significantly faster than
equivalent cells expressing an shRNA against Bmi1 or a
scrambled shRNA control (Figure 1c). We then compared the
respective miRNA expression profiles (Microarray v1.0) of B+
and sh-Bmi1 CPCs as described,29 and considered miRNAs
that showed a significant upregulation in B+ CPCs and a
reduction in sh-Bmi1 CPCs. From these results (GSE66813),
we compiled a short list of candidate miRNAs showing
Bmi1-dependent changes in expression (Supplementary
Figure S3a). The expression profile of three miRNAs,
miR-300, miR-188, and miR-362, was validated by RT-qPCR,
but miR-346 was not confirmed (Figure 1d). The expression
profile of the three confirmed miRNAs in CPCs corresponded
to miR-3624miR-1884miR-300 (Supplementary Figure
S3b). We next evaluated endogenous expression of these
miRNAs in CPCs with moderate-high expression of Bmi1. To
obtain this population, we marked Bmi1-expressing cells in
the mouse and traced their descendants using an inducible
Bmi1 CreERT2 strain30 crossed to a Rosa26-floxed yellow
fluorescent protein (YFP) reporter line. Induction of Cre
recombination by tamoxifen results in permanent expression
of YFP in Bmi1-expressing cells and their progeny
(Figure 1e). Subsequently, we compared CPC-B+ cells
labeled by YFP (YFP+) with the remaining CPC compartment
(YFP− ). Results confirmed an upregulation of miR-300 in the
YFP+ (CPC-B+) population, but not miR-188 or miR-362,
which were not overrepresented in the YFP− population
(Figure 1f). We validated this result in other cell lines.
Accordingly, overexpression of Bmi1 in mouse embryonic
fibroblasts (MEFs) and adipose tissue-derived MSCs induced
the upregulation of miR-300 relative to control cells (GFP),
although the relative increase was cell-type dependent
(Figure 1g). Specifically, Bmi1-induced upregulation of
miR-300 in CPCs (1.35-fold) was found to be similar to
MSCs (1.5-fold), but lower than that observed in MEFs
(4.3-fold). Taken together, these results suggest that Bmi1
might directly or indirectly regulate miR-300 expression.
miR-300 counteracts CPC replicative senescence.
Because Bmi1 upregulation increased cellular proliferation,
we questioned whether this was mediated by miR-300. We
therefore overexpressed miR-300 in CPCs using a non-viral
piggyBac vector (Supplementary Figure S2b). CPC-miR-300
cells exhibited a ≈5-fold increase in miR-300 compared with
control (CPC-GFP) cells, whereas CPC-B+ cells had a ≈1.7-
fold increase (Supplementary Figure S3c). Growth rates of
CPC-miR-300 and CPC-B+ cells, at all points analyzed, were
significantly higher than CPC-GFP cells (Figure 2a). This
increase in growth was not the result of changes in apoptosis
since annexin V staining was equivalent in the three groups
(Figure 2b, top left); however, significant differences were
found in the proportion of senescent cells measured by
β-galactosidase activity (Figure 2b, right panels). Accordingly,
the number of β-Gal+ cells was reduced 2.2-fold in
CPC-miR-300 and 6-fold in CPC-B+ populations compared
with control (Figure 2b, bottom left), suggesting that
miR-300 overexpression contributes to reduce and/or delay
senescence. Consistent with a modification in senescence
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development, differences were found in cell-cycle distribution
in miR-300-expressing cells (Supplementary Figure S4).
Gene expression analysis of cell-cycle senescence-
associated and stemness markers in CPC-miR-300 and
CPC-B+ cells demonstrated a significant upregulation in p19,
c-myc, Nanog, and Oct4 levels and a clear reduction in p16
levels (Figures 2c and d). To further examine whether
miR-300 is a relevant downstream effector of Bmi1, we
knocked down miR-300 expression in CPC-miR-300 and
CPC-B+ cells using anti-miR-300 oligonucleotides. We titrated
Figure 1 miR-300 expression is increased in Bmi1-overexpressing cells. CPCs were transduced with lentiviral vectors expressing Bmi1, sh-Scramble (encoding a negative
control shRNA), and sh-Bmi1. Transduced cells were purified by FACS. Bmi1 expression was assessed in purified cells by (a) RT-qPCR and (b) western blot. (c) Cumulative
population doubling (CPD) was estimated in CPC-B+ (closed circles), CPC-Scramble (gray squares), and CPC-sh-Bmi1 (triangles) cells. (d) RT-qPCR validation of the array
results for miR-300, miR-188, and miR-362; miR-346 was not validated. (e) Isolation of an identified primary subpopulation of Sca1-CPCs characterized by moderate-high
expression of Bmi1 using conditional Bmi1-YFP mice. (f) Comparison of miRNA expression in Sca1 compartments (YFP+ versus YFP− ). (g) Relative expression of miR-300 in
correlation with Bmi1 expression in cardiac progenitor cells (CPCs), mouse embryonic fibroblasts (MEFs), and mesenchymal stem cells (MSCs). ***Po0.001, **Po0.01,
*Po0.05 (two-way ANOVA followed by Bonferroni post-test; means± S.E.M., n= 5)
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the anti-miR concentration required to achieve at least
a 50% reduction of miR-300 expression in both cell lines
(Supplementary Figure S5). Results showed that anti-
miR-300 (50 pmol) suppressed the Bmi1-mediated effect on
several target genes (Figures 2c and d). In particular, BMI1-
induced Oct4 expression was fully dependent on miR-300.
Thus, knockdown of miR-300 in CPC-B+ and CPC-miR-300
cells reduced Oct4 expression to basal levels compared with
control cells. Furthermore, miR-300 overexpression induced
an upregulation of Oct4 mRNA to levels similar to those in
CPC-B+ cells (Figures 2c and d). Collectively, these results
suggest that miR-300 is necessary for Bmi1-dependent
expression of genes involved in cell-cycle dynamics, which
might preserve CPCs in a more undifferentiated state.
Indeed, genes related to multipotency and stemness were
found to be overrepresented in CPC-B+ and CPC-miR-300
cells (Figures 2c and d), and recovered to normal levels
when miR-300 was downregulated. In summary, miR-300
enhances the expression of a panel of multipotent genes,
indicating a plausible association with the maintenance of
CPCs in a more undifferentiated state.
miR-300 in the Dlk1-Dio3 context. In humans, miR-300
localizes to a dense miRNA cluster residing in chromosome
14, region 14q32.31 (DLK1-MEG3; Figure 3a). In the
mouse, this region corresponds to the Dlk1/Gtl2 domain
located on chromosome 12qF1.31 Detailed miRNA array
expression analysis of the whole miRNA-encoding locus in
CPC-B+ and CPC-sh-Bmi1 cells showed that miR-300 was
the only miRNA significantly modulated by overexpression of
Figure 2 miR-300 delays CPC senescence. (a) Cumulative population doubling over several culture passages of CPC-GFP (closed circles), CPC-miR-300 (gray squares),
and CPC-Bmi1(B+; triangles). (b) Apoptosis and senescence determined by annexin V staining (left upper panel) and β-gal staining (left lower panel), respectively; the right
panels show representative β-gal staining images. Bars, 100 μm. (c, d) Panels of relative expression levels of p19 and p16 (c) and multipotency-related genes (d) in CPC-
manipulated cells; where indicated, cells were transfected with mirVana miR-300 inhibitor. ***Po0.001; *Po0.05; ns, not significant (two-way ANOVA followed by Bonferroni
post-test; means± S.E.M., n= 5)
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Bmi1 (Figure 3b). This was confirmed by RT-qPCR analysis
of neighboring miRNAs (Figure 3c). Because DLK1-MEG3
regulation is dependent on polycomb-containing complexes,28
we assessed whether miR-300 could modulate members of
the polycomb complexes PRC1 and PRC2. We found a
modest decrease in the expression of Suz12, Ezh1, and
Jarid2 in CPC-miR-300 cells relative to CPC-GFP cultures
(Figure 3d). In contrast, CPC-B+ cells displayed a different
expression pattern, with a moderate increase in Eed and
Suz12 expression and a significant upregulation of Ezh2 and
Jarid2 (Figure 3d). Additionally, we found that modulation of
miR-300 expression also affected other elements of the
DLK1-MEG3 domain in different cell types (Figure 3e), which
was contingent on Bmi1 regulation (Supplementary Figure S6).
Accordingly, miR-300 overexpression provoked a decrease in
Dlk1 mRNA levels in CPCs and MSCs, but not in MEFs
(Figure 3e), suggesting a context-dependent regulation. This
effect was also observed for Meg3, which was reduced by
miR-300 overexpression in CPCs, but was increased in
MSCs (Figure 3e). Collectively, these data illustrate the great
complexity of the regulatory mechanisms underlying gene
expression at this locus (reviewed in Royo and Cavaille32),
but also highlight the apparent selectivity of Bmi1 for miR-300
expression and the consequent impact on some elements of
the DLK1-MEG3 domain.
Forced expression of miR-300 impairs CPC differentiation.
To test the role of miR-300 in CPC differentiation, cells were
Figure 3 miR-300 belongs to the imprinted Dlk1-Dio3 cluster. (a) Simplified map (5′→ 3′) of the mouse DlK-1-Dio3 cluster (chromosome 12qF1); miR-300 is shown. (b) miR
array results at the DlK-1-Dio3 cluster. (c) Direct validation by RT-qPCR of miR-300 neighbors, miR-381, miR-376b, and miR-654, confirmed the specificity of association of Bmi1
and increased expression of miR-300. (d) RT-qPCR analysis of different polycomb repressor complex 1/2 members and recruiters in CPC-GFP, CPC-B+, and CPC-miR-300 cells.
(e) RT-qPCR analysis of different Dlk1-Dio3 cluster inductors in CPC-miR-300, MEF-miR-300, and MSC-miR-300 cells relative to their respective control (−GFP) cultures.
***Po0.001, **Po0.01, *Po0.05 (two-way ANOVA followed by Bonferroni post-test; means± S.E.M., n= 5)
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first allowed to spontaneously differentiate in culture and
endothelial commitment was measured. CPC-GFP cells, but
not CPC-miR-300 or CPC-B+ cells, formed reticular struc-
tures after 10–12 days (Figure 4a, brightfield), which were
positive for CD31 (Figure 4a). Moreover, mRNA analysis of
endothelial markers revealed that Tie2 and vWf expression
was significantly reduced in CPC-miR-300 and CPC-B+ cells
compared with control CPC-GFP cells (Figure 4b). These
data suggest a functional impairment of endothelial cell
differentiation in miR-300 and Bmi1-expressing cells. To test
the generality of this response, we used the same cell
populations and induced cardiac differentiation by the
hanging drop method. After 6 days in culture, cardiospheres
from CPC-miR-300 and CPC-B+ cells were significantly
larger than those formed from CPC-GFP cells (Figure 4c),
corroborating the finding of increased proliferation potential
(Figure 2a). Additionally, knockdown of miR-300 in CPC-
miR-300 cells led to a significant reduction in cardiosphere
size (Figure 4c, right panel). Following retinoic acid treatment
to promote cardiac differentiation, plated CPC-B+ cardio-
spheres presented an apparently slower differentiation kinetic
as observed by a reduction in cell spreading compared with
control cells. Also, CPC-miR-300 cardiospheres continued to
proliferate with minimal differentiation compared with
CPC-GFP control cells, which showed greater expansion
(Figure 4d). Time course analysis of cardiac marker gene
expression revealed that, compared with control cells, levels
of a-MHC, Nkx2.5, and Tbx5 were significantly reduced in
Figure 4 miR-300 diminishes CPC differentiation potential in cardiospheres. (a) Representative images of spontaneous endothelial differentiation in transduced cells after
10–12 days of differentiation. Arrows indicate tubular structures in brightfield, which were positive for CD31. Bars, 200 μm. (b) RT-qPCR analysis of endothelial genes (Tie2 and
vWF) in CPC-GFP (black bars), CPC-miR-300 (gray bars), and CPC-B+ (white bars) cells. (c) Representative cardiosphere images at day 6 of differentiation. Bars, 100 μm (left).
Relative cardiosphere size (right). (d) Cardiac differentiation induced by retinoic acid; representative images of transfected CPCs at day (d)7, d10, and d14 of the differentiation
protocol. Bars, 200 μm. (e) Selected cardiac genes were measured by RT-qPCR in transfected cells during differentiation (d0, d10, and d14). (f) Western blotting of total protein
extracts was performed at d10. (g) RT-qPCR analysis of selected cardiac genes in CPCs transfected with mirVana miR-300 inhibitor. ***Po0.001, **Po0.01, *Po0.05 (two-way
ANOVA followed by Bonferroni post-test; means±S.E.M., n= 6)
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CPC-B+ and CPC-miR-300 cells throughout the differentia-
tion period (Figure 4e). Indeed, at d14 of differentiation,
a-MHC gene expression was almost abolished in CPC-B+.
Of note, Nkx2.5 gene expression was scarcely detected at
any period in CPC-B+ and CPC-miR-300 (Figure 4e), and
this was confirmed by western blot analysis (Figure 4f).
Because Nkx2.5 is a critical cardiogenic transcription factor,30
its evident absence in these cells likely contributes to the
impaired cardiogenic differentiation observed. Finally, to
confirm that miR-300 is a downstream effector of Bmi1
during the early steps of CPC cardiogenic differentiation, we
analyzed Nkx2.5 and Tbx5 expression early after anti-
miR-300 transfection. Exposure to anti-miR-300 for as little
as 3 days resulted in a partial rescue of Nkx2.5 and Tbx5
expression in CPC-B+ and CPC-miR-300 cells compared
with control cells (Figure 4g).
miR-300/Bmi1 interaction network in CPC. Little is known
about the physiological roles of miR-300. We compared all
potential miR-300 target genes predicted by specialized
databases and Ingenuity Pathway Analysis (IPA) was used to
link the direct targets. The most significant targets found by
IPA are shown in Figure 5. These included genes in the Tgf-β
signaling pathways (Map2k3) and factors involved in verte-
brate cardiogenesis (Smad2, Mapk14, Bmpr1a) (Figure 5a).
The Tgf-β pathway is associated with the regulation of
cardiac differentiation.33 Another target, Map2k3, of the Fgf
signaling pathway has been also described to be important
incardiac differentiation34 and affects mainly the p38 Mapk
pathway.35,36 Eleven putative targets were selected for
validation (Figure 5b and Supplementary Figure S6).
RT-qPCR analysis revealed that Mef2a, Map2k3, Igfr1, and
Fgf1r expression was dependent on miR-300 expression,
and this decrease in expression could be reversed by
transfection of an anti-miR-300 (five shown in bold in
Figure 5a). A similar modulation was found in CPC-B+ cells
(Figure 5b). Expression of the remaining putative miR-300
targets tested was not influenced by miR-300, although all
were inhibited by Bmi1 overexpression (Supplementary
Figure S6). The finding of Bmi1 as a highly probable target
of miR-300 suggests that it could directly regulate Bmi1.
Because activation of Bmi1 in CPCs results in increased
levels of miR-300 (Figure 1), we tested whether miR-300
activation affected the levels of Bmi1 mRNA and protein. We
examined Bmi1 expression in CPC-B+ and CPC-miR-300
cells before and after transfection with anti-miR-300. Both cell
lines exhibited an increase in Bmi1 expression following
suppression of miR-300 expression (Figures 6a and b). These
data suggest that Bmi1 positively regulates miR-300 and,
reciprocally, miR-300 negatively regulates Bmi1 expression in
a negative feedback loop.
Taken together, our study provides evidence that miR-300
could play an important role in maintaining multipotent
cell status, favouring Oct4 transcription factor expression,
and negatively regulating differentiation. Since none
of the confirmed genes modulated by overexpression of
miR-300 or Bmi1 (Oct4, Nkx2.5, Tbx5, and vWF) are
predicted as direct targets (Figure 5), our results suggest a
non-direct effect.
Discussion
Bmi1 is required for the self-renewal of adult stem cells in
many tissues.3,6,30,37–39 Because Bmi1 knockdown reduces
proliferation of mouse CPCs (Figure 1), we attempted to
identify regulatory elements controlled by Bmi1. We used
lentiviral vectors to overexpress (B+) or inhibit (sh)
Bmi1, to study its function in CPCs. CPC-B+ cells had an
enhanced proliferation capacity relative to CPC-sh-Bmi1
cells, suggesting that Bmi1 is important for the maintenance
of some CPC primitive properties. Because miRNAs can
fine tune cell homeostasis,16,17 we screened for miRNAs
regulated by Bmi1. To the best of our knowledge, all miRNAs
identified in association with Bmi1 expression are inhibitors
(Supplementary Table S1). Therefore, we searched for
miRNAs that could be regulated by Bmi1 in CPCs, as
plausible modulators of stem cell function.
Figure 5 miR-300 regulatory potential. (a) Main plausible targets of miR-300
were identified by comparing all predicted miRNA target sites in miRWalk database
produced by Diana, Pictar4, miRanda, Pita, TargetScan, and RNA22 databases,
containing all the putative targets. Main miR-300 predicted targets with at least four
hits in these databases (indicated in the table) were selected. Asterisks indicate
tested targets (11 in total) and in bold-italic those validated targets. (b) RT-qPCR
analysis of CPC; where indicated, cells were transfected with mirVana miR-300
inhibitor. ***Po0.001, **Po0.01, *Po0.05 (two-way ANOVA followed by Bonferroni
post-test; means± S.E.M., n= 5)
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We confirmed that miR-300 is upregulated when Bmi1
levels are high. Also, miR-300 is highly expressed in a primary
subpopulation of CPCs characterized by medium-high
expression of Bmi1. Presumably, because of the compara-
tively low basal expression of miR-300 (Supplementary Figure
S3b), it was not included in a recently published study on the
miRNA repertoire of adult mouse CPCs.40 Expression of Bmi1
in other murine cell lineages (MEFs and MSCs) consistently
activated miR-300 expression, although the levels of over-
expression were variable. All these results suggest that Bmi1
regulates miR-300. BMI1 is known as a transcriptional
repressor.7 To upregulate c-myc mRNA, Bmi1 activates the
Wnt pathway by repressing the Dickkopf (Dkk) family of Wnt
inhibitors. Repression of Dkk genes by Bmi1, in particular
Dkk1, drives the upregulation of Wnt and finally the Wnt target
gene, c-myc.11 We hypothesize that a similar mechanism of
suppression of a transcriptional repressor may operate to
activate miR-300 when Bmi1 is overrepresented.
Bmi1 plays a central role in senescence and aging,
regulating the expression of relevant genes involved in aging
and cancer.41–43 Overexpression of Bmi1 results in repression
of the tumor suppressor p16INK4a, which has emerged as a
major regulator of aging and age-associated pathologies.44
We show that in CPCs,Bmi1, andmiR-300 oppositely regulate
expression of p16Ink4a and p19ARF. Expression of p16Ink4a
is decreased in CPCs upon Bmi1 and miR-300 upregulation
(Figure 2c); in contrast, p19ARF levels are upregulated. These
two genes are localized in the same locus, sharing the
common exons 2 and 3, but differing in their first exons and
their respective promoters. As neither p16Ink4a or p19ARF
are miR-300 targets, the present evidence suggests that the
observed changes to p16INK4a and p19ARF expression are
due mainly to changes in the transcriptional activity of their
respective promoters. This effect on the INK4a/ARF locus has
been also observed in cells treated with histone deacetylase
inhibitors, with consequences for chromatin remodeling.45 It is
possible that variations in BMI1 protein levels could affect
PRC1 complex activity and chromatin structure; such changes
seem to alter INK4a/ARF transcription in a way similar to
histone deacetylase inhibitors. We hypothesize that the
DLK1-MEG3 cluster, where miR-300 is localized, could be
regulated in a similar manner.
It has previously been demonstrated that p16Ink4a accu-
mulates in conjunction with p38 activation in ras-induced
senescent cells, and that this accumulation is essential for
senescence.35 Although prevention of senescence in
CPC-miR-300 cells is less effective than in CPC-B+, p16
levels are significantly reduced in CPC-miR-300 cells. This
could be related to the different levels of overexpression of
miR-300 in the cell populations (Supplementary Figure S3c).
Thus, it is possible that miR-300 upregulation may at least
partially account for the downregulation of p16Ink4a and the
p38 pathway, thereby bypassing cell senescence. Since the
most important known senescence-relevant target of Bmi1 is
p16Ink4a, reduction of senescence in CPCs by miR-300 is
almost certainly associated with reduction of p16Ink4a
expression. In agreement with this, CPC-miR-300 cells
increase the expression levels of Oct4. Additionally, it has
been recently shown that the Oct4/p16Ink4a ratio directly
correlates with culture life span. This result suggests that low
p16Ink4a and high Oct4 levels govern the senescent state of
MSCs and therefore may be a good predictor of in vitro
viability.45 We speculate that the same principle operates
in CPCs.
Forced expression of miR-300 reduced spontaneous
endothelial differentiation of CPCs, and a similar effect was
obtained after Bmi1 overexpression. Cardiac differentiation
induced by retinoic acid was also reduced in CPC-miR-300
cells. These cells generated similar cardiosphere-type bodies
to control cells (d0–d8), but did not differentiate further. This
blockage seemed to be even stronger than that observed in
CPC-B+ cells. From a panel of critical cardiogenic genes
analyzed, the significant reduction found in the expression of
Nkx2.5 would be sufficient to explain the phenotype
Figure 6 Bmi1/miR-300 negative feedback loop. (a) RT-qPCR analysis of Bmi1 expression in CPC-GFP, CPC-miR-300, and CPC-B+ cells, before and after treatment with the
antagomiR. (b) Bmi1 protein levels measured by western blot; α-tubulin was used as a loading control. ***Po0.001, **Po0.01 (two-way ANOVA followed by Bonferroni post-test;
means± S.E.M., n= 5)
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observed.46 BecauseNkx2.5 is not a plausible direct target for
miR-300 (Figure 5), we infer that this effect is indirect.
In conclusion, miR-300 is a new member of the family of
genes that control stem cell function regulated by Bmi1 in
multipotent CSCs. miR-300 favors maintenance of the
undifferentiated state, inhibits differentiation, and establishes
a negative feedback loop to control levels of Bmi1.
Materials and Methods
Animals. C57BL/6 mice (8–12 weeks old) were provided by Charles River
Laboratories (Wilmington, MA, USA). Where indicated, Bmi1CreER/+; Rosa26YFP/+
(Bmi1-YFP) mice were generated by crossing Bmi1CreER/+ mice27 with Rosa26YFP/+
reporter mice (Valiente-Alendí et al. in press). Bmi1CreER/+; Rosa26YFP/+ double
heterozygous male and female mice were injected intraperitoneally with tamoxifen
(TM; Sigma; 9 mg per 40 g of body weight), every 24 h on three consecutive days
between postnatal days 30 (P30) and P60. Animals were maintained and handled
according to the recommendations of the CNIC Institutional Ethics Committee.
Lentiviral construction and non-viral vectors. Lentivirus production
and titration were carried out as described.47 Viral supernatant stocks contained
1 × 107 TU/ml, with a 1:100 TU/physical particles ratio as measured by qPCR. Cells
were transduced with cleared supernatants at a multiplicity of infection of 10, in 3 ml
of culture medium and polybrene (Sigma) at 8 μg/ml, for 8 h. Then, inoculum was
removed and cell cultures were refreshed with medium before assay.
Cellular transfection. Non-viral piggy-bac vectors (1–2 μg) were
co-transfected with mouse transposase-expression vector (0.5 μg) in SCA1+ cells,
MEFs, and MSCs, using Lipofectamine 2000 Transfection Reagent (11668-027,
Sigma). MirVana miRNA inhibitor (Applied Biosystems, Carlsbad, CA, USA) was used
to knockdown mir-300 expression in a separate set of experiments. Transfection
studies, in parallel with negative control miRNA inhibitor experiments, were carried out
with lipofectamine RNAiMax Transfection Reagent (13778030-Sigma).
Isolation of SCA1+ and Bmi1+ CPC cells from adult heart and
cell culture. Sca1+ CPCs were isolated essentially as previously described.48
Enrichment for SCA1+ cells was achieved by incubating cells with a SCA1-
biotinylated rat antibody (ab25196; Abcam, Cambridge, UK) and anti-rat kappa
microbeads (Miltenyi Biotec, Madrid, Spain; 130-047-401), followed by purification
with magnetic selection. Purified cells were plated in culture plates precoated with
0.1% gelatin and were maintained at 37 °C, 3% oxygen with the corresponding
medium (IMDM, 10% FCS, 1% penicillin and streptomycin, and 1% L-glutamine,
supplemented with 10 ng/ml EGF (E9644, Sigma), 20 ng/ml FGF (450-33, Pretech,
London, UK), and LIF (103 U; ESG1107, Millipore, Madrid, Spain). Medium was
refreshed every 2 days. Cells were passaged at 70–80% confluency by
trypsinization.
Bmi1+ CPC cells were obtained from hearts of Bmi1-YFP mice 5 days after TM
induction. Hearts were perfused and processed as above. The resulting single-cell
suspension was passed through a 40 μm filter to remove debris. YFP+ cells were
separated from the total heart mass with a BD FacsAria II Special Order System cell
sorter fitted with a 488 nm laser to excite YFP (collected in the 525/550 channel). To
discriminate YFP+ cells from autoflorescent cells, a 488 nm laser was used to excite
cells, followed by collection in the 585 channel (phycoerythrin). Purified YFP+ cells
were cultured at 37 oC, 3% O2 and 5% CO2 in the same expansion medium used for
Sca1+ cells.
MicroRNA microarray. After SCA1+CPC transduction of the indicated
lentiviral vectors (Supplementary Figure S2a), positively transduced cells were
sorted, briefly expanded, and total RNA was isolated using the mirVana kit (Ambion,
Madrid, Spain). RNA was quantified and integrity was checked by agarose gel
electrophoresis. The total RNA required for analysis (500 ng) was prepared in 10 μl
RNase-free water and analyzed using Agilent miRNA microarrays (Microarray v1.0).
After normalization, only those probes present in at least one sample and with
average expression over the 20th percentile of all average expressions were
considered for further analysis (197 miRNAs). We then used lineal models as
implemented in the limma Bioconductor package.26 We considered the
experimenter as a random variable. The analysis was performed at the CNIC
Bioinformatics Unit.
Endothelial and retinoic acid-induced cardiac differentiation. For
endothelial differentiation, SCA1+ cells were cultured for 10 days in the above-
indicated expansion conditions until spontaneous tubular structures appeared. For
cardiac differentiation, SCA1+ cells were trypsinized and diluted to 50 000 cells/ml.
Cardiospheres were prepared using hanging drop culture (20 μl approx 1000 cells)
for 3 days in DMEM GlutaMax supplemented with 20% FBS, 1% non-essential amino
acids, and β-mercaptoethanol. Cardiospheres were harvested, washed, and cultured
for three additional days on nonadherent Petri culture dishes (10 cm) in fresh medium.
Cardiospheres were then subsequently treated with all-trans retinoic acid (10 nM) in
DMEM GlutaMax supplemented with 15% FBS, 1% non-essential amino acids, and
β-mercaptoetanol (50 μM). The medium was replenished every 2 days.
Apoptosis and senescence assays. To determine programmed cell
death of SCA1+ cells, cells were harvested and examined for annexin V staining
(APC-conjugated; 550474, BD Pharmingen, Madrid, Spain), using an apoptosis
detection kit (556570 BD Pharmingen). For detection of senescence detection, cells
were cultured to a density of 20 000 cells/cm2 in β-galactosidase staining buffer for
24 h (Cell Signaling Technology, Danvers, MA, USA). Cells were then fixed and
stained.
Immunofluorescence. For immunostaining, cells were fixed in 4% paraf-
ormaldehyde in PBS for 10 min at room temperature. After washing three
times in PBS – 0.1% BSA for 5 min, cells were permeabilized with 0.2% Triton
(Sigma, T9284) in PBS for 20 min, and washed in PBS – 0.1% BSA. Primary
antibody against CD31 (MAB1398Z, Millipore) was diluted in PBS – 0.1% BSA to
1/200 and incubated overnight at 4 °C. After washing, cells were incubated with a
FITC-conjugated goat anti-hamster secondary antibody (127-095-099, Jackson, Bar
Harbor, ME, USA) used at a 1/1000 dilution in the presence of DAPI for 45 min (1 h
at room temperature). Vectashield mounting medium without DAPI (Vectors Lab,
Burlingame, CA, USA; H-1000) was applied to all slides. Fluorescent images were
taken using a Nikon A1-R inverted confocal microscope.
Gene expression analysis and western blotting. Total RNA was
isolated from cultured cells using the Direct-zol RNA Miniprep Kit (Zymo, Irvine, CA,
USA) and reverse transcribed with the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems) for mRNA and with the TaqMan MicroRNA Reverse
Transcription Kit (4366596, Applied Biosystems, Madrid, Spain) for miRNAs.
Complementary DNAs were analyzed by real-time PCR using the Power SYBR
Green PCR Master Mix (Applied Biosystems) for mRNA and No AmpErase
TaqMan 2X Universal PCR Master Mix (S08590, Applied Biosystems) for miRNA.
Amplification, detection, and data analysis were carried out with an ABI PRISM
7900HT Sequence Detection System. The crossing threshold values for individual
mRNAs were normalized to GusB expression for mRNAs and U6 for miRNAs.
Changes in mRNA expression were denoted as the fold change relative to the
control (see supplementary Table S2 for primers used).
For western blotting, total proteins were isolated using RIPA buffer (25 mM
Tris–HCl pH 7.6, 150 mM NaCl, 1% NP-40, 1% sodium deoxycholate, and 0.1% SDS)
and quantified by the DC Protein assay (Bio-Rad). Approximately 50 μg of protein
was resolved on each lane on 10% SDS-PAGE gels, electrotransferred onto
nitrocellulose membrane, and probed with specific antibodies (see Supplementary
Table S3 for antibodies used).
Statistics. Data were analyzed by two-way ANOVA and Student’s t-test.
Error bars represent S.E.M. In all corresponding figures, ∗Po0.05, ∗∗Po0.01,
∗∗∗Po0.001, and ns P40.05.
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